Eganelisib (Standard)
Eganelisib (Standard) is the analytical standard of Eganelisib (HY-100716). This product is intended for research and analytical applications. Eganelisib (IPI549) is a potent and selective PI3Kγ inhibitor with an IC50 of 16 nM. Eganelisib shows >100-fold selectivity over other lipid and protein kinases.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98%
- CAS No.: 1693758-51-8
- Formule: C30H24N8O2
- Masse moléculaire:528.56
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-100716
EganelisibPI3Kγ Inhibitor -
HY-15244
AlpelisibPI3Kα Inhibitor -
HY-102031
LinperlisibPI3Kδ Inhibitor -
HY-12644
AcalisibPI3K Inhibitor -
HY-101562
InavolisibPI3Kα Inhibitor -
HY-12869
AZD-8835PI3Kα/δ Inhibitor -
HY-70063
BuparlisibPI3K Inhibitor -
HY-109068
ParsaclisibPI3Kδ Inhibitor -
HY-17044
DuvelisibPI3Kδ Inhibitor -
HY-101272
GDC-0326PI3Kα Inhibitor -
HY-13898
TaselisibPIK3CA Inhibitor -
HY-12285
Serabelisibp110α Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 1693758-51-8
-
Masse moléculaire 528.56
-
Formule C30H24N8O2
-
SMILES
O=C(C1=C2N=CC=CN2N=C1N)N[C@H](C3=CC4=C(C(N3C5=CC=CC=C5)=O)C(C#CC6=CN(C)N=C6)=CC=C4)C
-
Synonyms
IPI-549 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Evans CA, et al. Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate. ACS Med Chem Lett. 2016 Jul 22;7(9):862-7. [Content Brief]
[2]. De Henau O, et al. Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells. Nature. 2016 Nov 17;539(7629):443-447. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Eganelisib (Standard) Related Classifications
HY-100716R Related Classifications
Powered by Bioz